The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist (Q42716663)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist |
scientific article |
Statements
1 reference
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist (English)
1 reference
Martin H Bolli
1 reference
Christoph Boss
1 reference
Christoph Binkert
1 reference
Stephan Buchmann
1 reference
Daniel Bur
1 reference
Patrick Hess
1 reference
Marc Iglarz
1 reference
Solange Meyer
1 reference
Josiane Rein
1 reference
Markus Rey
1 reference
Alexander Treiber
1 reference
Martine Clozel
1 reference
Walter Fischli
1 reference
Thomas Weller
1 reference
16 August 2012
1 reference
1 reference
55
1 reference
17
1 reference
7849-7861
1 reference
Identifiers
1 reference
1 reference